SCHEMBL15925944

SCHEMBL15925944

Cc1ccnc2c1OCC(=O)N2

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.42
PDE3B Q13370 3/20 0.39
PDE3A Q14432 3/20 0.39
NR3C2 P08235 7/20 0.37
PGR P06401 5/20 0.37
PARP1 P09874 1/20 0.36
NR3C1 P04150 4/20 0.36
BRD4 O60885 1/20 0.36
CREBBP Q92793 1/20 0.36
AR P10275 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NSD2 O96028 1/20 0.34
DRD2 P14416 1/20 0.34
DRD4 P21917 1/20 0.34
DRD3 P35462 1/20 0.34
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10298660 0.80 PARP1 (0.44) MMP12PDE3BPDE3ANR3C2PARP1
SCHEMBL17766364 0.79 PDE3B (0.36) MMP12PDE3BPDE3ANR3C2PGR
SCHEMBL4251063 0.79 MALT1 (0.38) MMP12PDE3BPDE3ANR3C2PGR
SCHEMBL27051279 0.79 ADRB1 (0.36) MMP12PDE3BPDE3APARP1CYP11B1
SCHEMBL12947787 0.79 MMP12 (0.36) MMP12PDE3BPDE3ANR3C2PGR
SCHEMBL19153473 0.76 MMP12 (0.39) MMP12PDE3BPDE3ANR3C2PGR
SCHEMBL23318178 0.75 NR3C2 (0.39) MMP12PDE3BPDE3ANR3C2PARP1
SCHEMBL32675632 0.75 NR3C2 (0.39) MMP12PDE3BPDE3ANR3C2PARP1
SCHEMBL1851941 0.74 CREBBP (0.58) MMP12NR3C2PGRPARP1NR3C1
SCHEMBL11912374 0.73 DRD2 (0.42) MMP12PDE3BPDE3ANR3C2PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9139589-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2015-09-22 US disclosed
US-20150175563-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARM INC (US) 2015-06-25 US disclosed
US-20150175593-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARM INC (US) 2015-06-25 US disclosed
US-8796268-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-05 US disclosed
US-8796271-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175563-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 MMP12 1537/4885PDE3B 1408/4885PDE3A 1855/4885
US-20150175593-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 MMP12 1674/4885PDE3B 1410/4885PDE3A 1928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.